Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Comment by august202013on Jul 15, 2021 9:53am
156 Views
Post# 33548626

RE:RE:RE:MedMira Closes New Equity Investment for Future Growth

RE:RE:RE:MedMira Closes New Equity Investment for Future GrowthNOTMYNAME1 TODAY'S SMALL INVESTORS KNOWS THAT WITHOUT INCOME FROM BUSINESS WHICH IS COVID19 TEST KIT PLUS NOW MIR WILL CONTINUE TO LOOK FOR MORE FUNDS AT EXPENCE OF EXISTING SHAREHOLDERS THROUGH DILUTION OR ISSUANCE OF MORE MIR SHARES. IS NOT GOOD !

SEE THE COVID19 TEST KIT PLUS SHOULD BE GOOD AS THAT IS YOUR ONLY CORE BUSINESS BLOOD. WHEN YOU COME WITH A WONDERFUL DISCOVERY AT THE PERFECT TIME IT MUST ME MARKET WHEN IT IS MOST NEEDED. IF PROBLEM ARISE AT ONE MARKET SEGMENT HAVE TO MARKET TO THE OTHER WHEN IS MUCH NEEDED. NOT AFTERWARDS WHEN EVERYTHING NORMALISE. BY THEN DO MIR GET DR CHAN TO DEVISE ANOTHER PRODUCT AND SUBJECT TO SAME TAMPLATE AND SUBJECT MIR TO ANOTHER WAITING AND THEN BLAME GOD !

MIR IS A GOOD COMPANY AT A GOOD TIME BUT SCREWED DUE TO PROFESSIONAL NEGLIGENCE. SEE YOU ARE PAID FOR FORSIGHT TO STEER THE COMPANY TO MAKE MONEY NOT ALWAYS TO BLAME  OVERSIGHT OR USA FDA. THERE MARKET IS THE WHOLE WORLD DON'T SUBJECT/LIMIT YOURSELF TO USA. PLEASE WAKE UP MM FOR THE TRUST YOUR SHAREHOLDER AND YOUR FAMILY  PUT ON YOUR SHOULDERS.
<< Previous
Bullboard Posts
Next >>